The combined systems biology/ pharmacokinetic model allows us to study two different tumor cell alterations with elevated EGFR levels resulting from (i) an increased receptor synthesis rate; and (ii) a decreased receptor internalization rate. This evidence concerns the gene EGFR and neoplasm.